Gate News message. On April 3, according to The Information, the AI company Anthropic acquired the biotech startup Coefficient Bio for about $400 million. Anthropic is the developer of the Claude large language model, and this acquisition marks its expansion into the biotech sector.

Gate News reports that on March 28, Ark Invest Tracker data shows that Ark Invest continued to reduce its holdings in tech stocks on Friday, following a reduction in tech stocks and crypto ETFs on Thursday. They sold over 58,000 shares of NVIDIA and over 19,000 shares of AMD, accounting for 0.1%-0.15% of the total fund value. At the same time, Ark Invest bought shares in the biotech company Arcturus.

Ark Invest has recently significantly reduced its holdings in tech stocks and crypto ETFs, particularly in Nvidia and AMD. It only purchased biotech company Arcturus Therapeutics, indicating a shift in its investment focus from AI chips to medical innovation.

Biotech company NovaBay announced a strategic transformation, rebranding itself as Stablecoin Development Corporation to venture into the digital asset field, with its stock price increasing by about 19%. The company changed its stock ticker from NBY to SDEV and holds approximately 2.06 billion SKY tokens. This transition was facilitated by $134 million in private equity financing.

On-chain monitoring platform Lookonchain has discovered multiple recent Ethereum transfer records associated with vitalik.eth. Data shows that within three days, he sold a total of 2,961.5 ETH in batches, which was approximately $6.6 million at the time. The transactions were completed through the CoW protocol, executed in small, multiple transactions, and the on-chain settlement process was verified by Arkham. No hidden routing or mixer operation traces were found. From a historical perspective, this is not a temporary action. Vitalik has previously publicly stated that he would gradually transfer some ETH for long-term plans. Recently, he also transferred 16,384 ETH, worth over $43 million, some of which was used for his Kanro organization to support biotech research, open-source security, and public welfare projects. His past operations have always been carried out in a slow, planned manner, with no signs of abrupt liquidation.